Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis 期刊论文 出版模式: 开放获取 发表日期: 2025年8月26日 查看全文 Akhil Rajendra, Elliot Smith, Maria Agustina Perusini, Kenny Tang, Eshetu G. Atenafu, Aniket Bankar, Steven Chan, Marta B. Davidson, Vikas Gupta, Dawn Maze, Mark D. Minden, Guillaume Richard-Carpentier, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai 摘要